Health Care/Hospital

Antengene Appoints Former Celgene ANZ Medical Leader Dirk Hoenemann as Head of Medical Affairs in Asia Pacific Region & Early Clinical Development

SHANGHAI and MELBOURNE, Australia, July 13, 2020 /PRNewswire/ -- Antengene Corporation (Antengene) today announced the appointment ofDirk Hoenemann, M.D as VP, Head of Medical Affairs for Asia Pacific Region (APAC) and Early Clinical Development. He will report directly to Mr.Thomas Karalis, Head...

2020-07-13 06:00 4028

World's First FDA IDE Coronary Patient Treated With a DEB

NYON, Switzerland, July 11, 2020 /PRNewswire/ --  MedAlliance has announced enrollment of the first patient in its study ofSELUTION SLR™ 014 DEB  for the treatment of In-Stent Restenosis (ISR). This is the first DEB accepted by the FDA for its 'Breakthrough Progr...

2020-07-11 08:00 3156

Ocumension Therapeutics Launches Initial Public Offering on Hong Kong Stock Exchange

SHANGHAI, July 10, 2020 /PRNewswire/ -- Ocumension Therapeutics ("Ocumension"), aChina-based ophthalmic pharmaceutical platform company, has today launched its Initial Public Offering (IPO) of the company's stock on The Stock Exchange of Hong Kong (HKEX). Ocumension plans to offer 105,930,000 shar...

2020-07-10 21:55 19797

CS02 Changes the Landscape of Diabetes Treatment: CenterLab Announces Positive Topline Results of Phase 2 Trial

TAIPEI, July 10, 2020 /PRNewswire/ -- Center Laboratories Inc. (CenterLab: 4123.TWO), a pharmaceutical company dedicated in specialty drug product development, announced today that the anti-diabetic drug – CS02 meets its primary endpoint. The topline results of a phase 2 clinical trial of CS02...

2020-07-10 20:43 3744

Zhongchao Inc. Co-organizes China-Russia-Near East Gastrointestinal Academic Dialogue

SHANGHAI, July 10, 2020 /PRNewswire/ -- Zhongchao Inc. (NASDAQ: ZCMD) ("Zhongchao" or the "Company"), a healthcare services company offering patient management, online healthcare information, professional training and educational services, today announced that it co-organized a virtual panel ses...

2020-07-10 18:30 3621

Sedana Medical Announces Positive Top Line Result in Pivotal IsoConDa Study

STOCKHOLM, July 10, 2020 /PRNewswire/ -- Sedana Medical AB (publ) (SEDANA: FN Stockholm) today announced a positive top line result for the company's pivotal phase III study, IsoConDa. The study reached its primary endpoint; to show that IsoConDa (isoflurane), administered with AnaConDa, is an ef...

2020-07-10 13:32 1543

Merck Opens its Largest M Lab™ Collaboration Center in Shanghai

-- Focus on improving and optimizing drug discovery, development and manufacturing -- Integrated lab with customizable solutions, validation services, training and hands-on applications -- Shanghai center is newest and largest addition to Merck's global network of nine M Lab™ Collaboration Cente...

2020-07-10 13:00 3112

PolyU discovers the effect of chemical compound PTU on autophagy in zebrafish embryos, sheds light on cancer medication research

HONG KONG, July 10, 2020 /PRNewswire/ -- The zebrafish has been utilised as a model organism for biomedical research globally for half a century, mainly due to the high genetic similarity (over 70%) between zebrafish and human genes, with over 80% of human morbid genes related to at least one zeb...

2020-07-10 10:18 2376

Q Division Bringing Emerging Technology Expertise to Advanced Materials Pandemic Task Force

DAYTON, Ohio, July 9, 2020 /PRNewswire/ -- Q Division today announced their participation as commercial retail experts in the global Advanced Materials Pandemic Task Force (AMPT) - an international public-interest initiative focused on using Advanced Materials to solve some of humanity's most pre...

2020-07-09 22:00 1822

Laboratory Studies Confirm BETADINE(R) Antiseptic Products' Effectiveness Against COVID-19 Virus

SINGAPORE, July 9, 2020 /PRNewswire/ -- Mundipharma today announced that laboratory testing at the Duke-NUS Medical School in Singapore, has confirmed the effectiveness of its BETADINE® antiseptic products against the novel coronavirus (SARS-CoV-2) which causes COVID-19 disease. Testing has demo...

2020-07-09 21:27 3743

Frost & Sullivan Recognizes DrFirst for Solutions Providing Secure Communication, Collaboration, and Real-Time Access to Patient Information at the Point of Care

DrFirst wins Digital Health Data Industry New Product Innovation Award for its suite of products that improve healthcare providers' clinical view of patients' medical information and drug regimens SANTA CLARA, California, July 9, 2020 /PRNewswire/ -- Providers across multiple care settings requi...

2020-07-09 21:00 1592

New Report Reviews Global Hospital Practices in Pandemic Flu Response

SINGAPORE, July 9, 2020 /PRNewswire/ -- Eden Strategy Institute today unveiled a global review of hospital practices in dealing with flu pandemic, drawing novel and interesting insights from the current COVID-19 pandemic as well as from previous pandemics such as SARS, H1N1, and Ebola. This rese...

2020-07-09 17:19 1850

AGC Biologics Collaborates with Molecular Partners AG to Develop Anti-COVID-19 DARPin® Program

SEATTLE, July 9, 2020 /PRNewswire/ -- Global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO)AGC Biologics is partnering with clinical-stage biotech companyMolecular Partners AG to develop a new class of custom-built protein therapeutics known as DARPin®. AGC Biologics...

2020-07-09 13:00 2491

Men Are Discreet About Their Negative Body Confidence and Self-perception, Observes Dr Ivan Puah, Medical Director Of Amaris B. Clinic

SINGAPORE, July 9, 2020 /PRNewswire/ -- Dr Ivan Puah, Medical Director of Amaris B. Clinic, is seeing an increasing number of males seeking treatment for gynecomastia and surgical reduction of localised fat in recent years due to body dissatisfaction. Men, just like women, do care about their ...

2020-07-09 12:30 3106

Innovent Announces First Patient Dosed in a Phase 1b Clinical Trial of Sintilimab plus Surufatinib in Advanced Malignancies in China

SUZHOU, China, July 9, 2020 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, metabolic, autoimmune and other major diseases, today anno...

2020-07-09 08:00 12036

Paige Applauded by Frost & Sullivan for its Leading AI-based Computational Pathology Offering that Enables Fast and Accurate Cancer Diagnoses

Paige leveraged the world's largest dataset in pathology to develop an unparalleled computation pathology offering SANTA CLARA, California, July 8, 2020 /PRNewswire/ -- Based on its recent analysis of the North American AI-based digital pathology market, Frost & Sullivan recognizesPaige with the...

2020-07-08 23:40 1686

Frost & Sullivan Honors Leading Organizations in Asia-Pacific in an Inaugural Virtual Ceremony for the 2020 Asia-Pacific Best Practices Awards

SINGAPORE, July 8, 2020 /PRNewswire/ -- Frost & Sullivan honored Asia-Pacific's leading companies at the18th annual Asia-Pacific Best Practices Awards on 8 July in an inaugural virtual awards ceremony. A total of15 awards were presented to organizations for elevating performance benchmarks and fo...

2020-07-08 19:03 1778

Lipidor Signs Agreement With CRO for Implementation of Phase III Clinical Study of Drug Candidate AKP-02 Against Psoriasis

STOCKHOLM, July 8, 2020 /PRNewswire/ -- Lipidor AB (Nasdaq First North: LIPI) today announced an agreement with Cadila Pharmaceuticals, a leading Indian pharmaceutical company with extensive CRO capacity, to conduct a Phase III study for Lipidor's drug candidate AKP-02. The study is expected to c...

2020-07-08 14:57 1619

Sun Life Hong Kong Boosts Diabetes Awareness

HONG KONG, July 8, 2020 /PRNewswire/ -- Today marks the official release of Is Something Wrong with Granny?!, a children's picture book published by Diabetes Hongkong and sponsored by Sun Life Hong Kong Limited ("the Company" or "Sun Life Hong Kong"). Little Kwong, the protagonist of the story, i...

2020-07-08 14:54 2888

Rapidly Changing Behaviours In 2020 Are Accelerating Consumer Embrace of Digital, Health, and Sustainability Trends, Says PwC

NEW YORK, July 8, 2020 /PRNewswire/ --  * 45% of global consumers say healthcare is one of the top three reasons for living in a city * 69% of global consumers are more focused on mental health and well being * 43% of global consumer expect businesses to be accountable for their environment...

2020-07-08 12:00 3039
1 ... 444445446447448449450 ... 554